cervical radiculopathy (CR)
Conditions
Interventions
control group (usual care):Conventional treatment (neck flexion immobilization, pain medication)
experimental group:Angled Manual Traction (AMT) plus Usual Care
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age 40–75 years old; 2. Neck, shoulder, or arm pain in the past 24 hours with a Numeric Rating Scale (NRS) score of >= 4; 3. No previous AMT treatment; 4. Understands and voluntarily signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Having comorbidities that could contribute to cervicobrachialgia (e.g., shoulder bursitis, thoracic outlet syndrome, progressive muscular, cubital tunnel syndrome, tennis elbow, carpal tunnel syndrome, angina pectoris and pathological changes of cervical vertebrae like tuberculosis, neoplasms); 2. Having congenital spine diseases (scoliosis, abnormalities, developmental spinal stenosis, etc.), cervical surgery history, spinal cord injuries history, osteomyelitis, severe osteoporosis and other type of cervical spondylosis; 3. Having contraindications against nonsteroidal anti-inflammatory drugs (NSAIDs) or opiates (e.g., hypersensitivity to NSAIDs or opiates, active or relapsing peptic ulcer or gastrointestinal bleeding, NSAIDs-related gastrointestinal bleeding or perforation, gastrointestinal obstruction, hepatic failure, renal failure with GFR < 15 mL/min/1.73 m^2, heart failure with New York Heart Association (NYHA) class IV, bronchial asthma, and on prescribed monoamine oxidase (MAO) inhibitors (Isocarboxazid, Moclobemide, Phenelzine, etc.) within 2 weeks); 4. Having active malignancy; 5. Planning surgery during the study period; 6. Failing to understand and/or follow the study protocol due to disabilities (blindness, deafness, dumbness, intellectual disability, psychiatric disorder, etc.); 7. Gravida, lactating women, or individuals planning to conceive during the trial; 8. Participating in other clinical trials or planning to participate in other concurrent clinical studies; 9. Having any other conditions investigators deem inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cumulative cervicobrachial pain during the trial; | — |
Secondary
| Measure | Time frame |
|---|---|
| Zung’s self-rating anxiety (SAS);work productivity and activity impairment questionnaire: cervical radiculopathy (WPAI: CR);Zung’s self-rating depression (SDS);adverse event rate (AER);5-level version of the euroqol 5-dimensional descriptive system (EQ-5D-5L);upper extremity pain on numeric rating (NRS);intervention cost based on a societal perspective (including direct costs and indirect costs);grip strength;quality-adjusted life year (QALY) (utility measure);NSAID consumption per period;cervicobrachial pain on numeric rating (NRS);cumulative cervicobrachial pain during the trial (effect measure);shoulder pain on numeric rating (NRS);opiate consumption per period;cervicobrachialgia-related nighttime awakenings;numbness in arms on numeric rating (NRS);patient global impression of change (PGIC);disabilities of the arm, shoulder, and hand (QuickDASH);neck pain on numeric rating (NRS);neck disability index (NDI); | — |
Countries
China
Contacts
Public ContactLin Dingkun
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed